Dr. Alexa B. Adams specializes in the treatment of juvenile idiopathic arthritis, juvenile dermatomyositis, childhood systemic lupus and vasculitis of childhood. Throughout her career, Dr. Adams has won numerous awards, including the Distinguished house Staff Award, and has been an active member of several associations for medical professionals. She is currently an Associate Attending Pediatric Rheumatologist at Hospital for Special Surgery and Associate Professor of Clinical Pediatrics at the NYPH Weill Cornell Medical Center Department of Pediatrics. Dr. Adams serves as director of the HSS – Weill Cornell Pediatric Rheumatology Fellowship Training Program.
Juvenile Idiopathic Arthritis
Childhood Systemic Lupus
Vasculitis of Childhood
Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may have coverage subject to the availability of 'out-of-network' benefits.
Associate Attending Pediatrician, Hospital for Special Surgery
Associate Professor of Clinical Pediatrics, Weill Cornell Medical College
American College of Rheumatology – member
Childhood Arthritis and Rheumatology Research Alliance – member
Board Certified, Pediatrics
Board Certified, Pediatric Rheumatology
Castle Connolly Regional Top Doctor, 2014-2020
Castle Connolly Top Doctors in New York Metro Area, 2015-2021
New York Magazine Top Doctors, 2015-2017, 2020-2021
“My Doc Rocks” Award, Arthritis Foundation. September, 2012. Recognized by the Arthritis Foundation as “an outstanding medical professional who values her relationship with her patients”.
Distinguished House Staff Award, Cornell Medical Center Alumni Council, 2002
Alpha Omega Alpha, Medical Honor Society, 1999
Medical University of South Carolina, Charleston, SC, 1999
NewYork-Presbyterian Hospital, Weill Cornell Medical Center, 1999-2000
NewYork-Presbyterian Hospital, Weill Cornell Medical Center, 2000-2002
Chief Resident, Pediatrics – NewYork-Presbyterian Hospital, Weill Cornell Medical Center, 2002-2003
Hospital for Special Surgery, 2003-2006
Adams A. Last Minute Pediatrics – A Concise Review for the Specialty Boards. Associate Editor and Contributor. McGraw Hill, 2004.
Systemic Lupus Erythematosus: Etiology, Pathogenesis, Clinical Manifestations, and Management. Adams A, MacDermott EJ, Lehman TJA. Handbook of Systemic Autoimmune Diseases, Volume 6. Cimaz R, Lehman TJA eds. Pediatrics in Systemic Autoimmune Diseases. Elsevier, 2007, pp 65 -75.
Walters HM, Pan N, Lehman TJA, Adams A, Huang WT, Sitaras L, Cunningham-Rundles S, Walsh T, Toussi S. A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors. Clin Rheumatol. 2015 Mar;34(3):457-64. doi: 10.1007/s10067-014-2779-8. Epub 2014 Sep 18.
Sherman Y, Karanicolas R, DiMarco B, Pan N, Adams AB, Barinstein LV, Moorthy LN, Lehman TJ. Unrecognized Celiac Disease in Children Presenting for Rheumatology Evaluation. Pediatrics. 2015 Jul; 136(1):e68-75. doi: 10.1542/peds.2014-2379. Epub 2015 Jun 15.
Walters HM, Pan N, Lehman TJ, Adams A, Kalliolias GD, Zhu YS, Santiago F, Nguyen, J, Sitaras L, Cunningham-Rundles S, Walsh, TJ, Toussi SS. The impact of disease activity and tumor necrosis factor-a inhibitor therapy on cytokine levels in juvenile idiopathic arthritis. Clin Exp Immunol. 2016 Jun; 184(3): 308-17.
Nuruzzaman F, Sherman Y, Ostfeld BM, Adams AB, Pan N, Barinstein LV, Lehman TJ, Moorthy LN. Simple screening tool for assessing attention deficit in pediatric lupus. Lupus. 2016 Apr; 25(4):447-8.
Trachtman R, Wang CM, Murray E, Szymonifka J, Pan N, Adams AB, Taber SF, Onel KB, Mandl LA. PROMIS Computer Adaptive Tests and Their Correlation With Disease Activity in Juvenile Idiopathic Arthritis. J Clin Rheumatol. 2021 Jun 1;27(4):131-135. PMID: 31743268
For more publications, please see the PubMed listing.
Updates in Pediatric Gastroenterology, 2019. Weill Cornell Medical Center. Rheumatologic Manifestations of Inflammatory Bowel Disease. April, 2019
Pediatrics Grand Rounds. Weill Cornell Medical Center. Pediatric Rheumatology and COVID-19. May, 2020.
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of March 01, 2022, Dr. Adams reported no relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.